Lantheus Reports Higher Q3 Adjusted Earnings and Revenue

Lantheus’ third-quarter revenue edged higher year over year, while net income declined. Neuraceq growth, higher PYLARIFY and DEFINITY sales volume, and increased Flyrcado royalties and milestone payments drove revenue gains; lower PYLARIFY net sales prices and a SPECT comparison weighed on growth…